PNTG Quote, Financials, Valuation and Earnings

The Ensign Group, Inc. has a net margin of 3.01% compared to The Pennant Group, Inc.'s net margin of 6.47%. The Pennant Group, Inc.'s return on equity of 9.98% beat The Ensign Group, Inc.'s return on equity of 16.99%.

The Pennant Group, Inc. has a consensus price target of $37.50, signalling upside risk potential of 33.31%. On the other hand The Ensign Group, Inc. has an analysts' consensus of $208.20 which suggests that it could grow by 19.75%. Given that The Pennant Group, Inc. has higher upside potential than The Ensign Group, Inc., analysts believe The Pennant Group, Inc. is more attractive than The Ensign Group, Inc..

The Pennant Group, Inc. has a beta of 1.282, which suggesting that the stock is 28.198% more volatile than S&P 500. In comparison The Ensign Group, Inc. has a beta of 0.861, suggesting its less volatile than the S&P 500 by 13.903%.

The Pennant Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Ensign Group, Inc. offers a yield of 0.15% to investors and pays a quarterly dividend of $0.07 per share. The Pennant Group, Inc. pays -- of its earnings as a dividend. The Ensign Group, Inc. pays out 4.74% of its earnings as a dividend. The Ensign Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Pennant Group, Inc. quarterly revenues are $229M, which are smaller than The Ensign Group, Inc. quarterly revenues of $1.3B. The Pennant Group, Inc.'s net income of $6.9M is lower than The Ensign Group, Inc.'s net income of $83.9M. Notably, The Pennant Group, Inc.'s price-to-earnings ratio is 37.18x while The Ensign Group, Inc.'s PE ratio is 30.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Pennant Group, Inc. is 1.17x versus 2.10x for The Ensign Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Guardian Pharmacy Services, Inc. has a net margin of 3.01% compared to The Pennant Group, Inc.'s net margin of 2.54%. The Pennant Group, Inc.'s return on equity of 9.98% beat Guardian Pharmacy Services, Inc.'s return on equity of 24.04%.

The Pennant Group, Inc. has a consensus price target of $37.50, signalling upside risk potential of 33.31%. On the other hand Guardian Pharmacy Services, Inc. has an analysts' consensus of $34.75 which suggests that it could grow by 14.61%. Given that The Pennant Group, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe The Pennant Group, Inc. is more attractive than Guardian Pharmacy Services, Inc..

The Pennant Group, Inc. has a beta of 1.282, which suggesting that the stock is 28.198% more volatile than S&P 500. In comparison Guardian Pharmacy Services, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Pennant Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardian Pharmacy Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Pennant Group, Inc. pays -- of its earnings as a dividend. Guardian Pharmacy Services, Inc. pays out 128.01% of its earnings as a dividend.

The Pennant Group, Inc. quarterly revenues are $229M, which are smaller than Guardian Pharmacy Services, Inc. quarterly revenues of $377.4M. The Pennant Group, Inc.'s net income of $6.9M is lower than Guardian Pharmacy Services, Inc.'s net income of $9.6M. Notably, The Pennant Group, Inc.'s price-to-earnings ratio is 37.18x while Guardian Pharmacy Services, Inc.'s PE ratio is 47.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Pennant Group, Inc. is 1.17x versus 1.38x for Guardian Pharmacy Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Lifestance Health Group, Inc. has a net margin of 3.01% compared to The Pennant Group, Inc.'s net margin of 0.3%. The Pennant Group, Inc.'s return on equity of 9.98% beat Lifestance Health Group, Inc.'s return on equity of -0.62%.

The Pennant Group, Inc. has a consensus price target of $37.50, signalling upside risk potential of 33.31%. On the other hand Lifestance Health Group, Inc. has an analysts' consensus of $8.89 which suggests that it could grow by 20.12%. Given that The Pennant Group, Inc. has higher upside potential than Lifestance Health Group, Inc., analysts believe The Pennant Group, Inc. is more attractive than Lifestance Health Group, Inc..

The Pennant Group, Inc. has a beta of 1.282, which suggesting that the stock is 28.198% more volatile than S&P 500. In comparison Lifestance Health Group, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Pennant Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lifestance Health Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Pennant Group, Inc. pays -- of its earnings as a dividend. Lifestance Health Group, Inc. pays out -- of its earnings as a dividend.

The Pennant Group, Inc. quarterly revenues are $229M, which are smaller than Lifestance Health Group, Inc. quarterly revenues of $363.8M. The Pennant Group, Inc.'s net income of $6.9M is higher than Lifestance Health Group, Inc.'s net income of $1.1M. Notably, The Pennant Group, Inc.'s price-to-earnings ratio is 37.18x while Lifestance Health Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Pennant Group, Inc. is 1.17x versus 2.10x for Lifestance Health Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

PACS Group, Inc. has a net margin of 3.01% compared to The Pennant Group, Inc.'s net margin of 3.89%. The Pennant Group, Inc.'s return on equity of 9.98% beat PACS Group, Inc.'s return on equity of 21.93%.

The Pennant Group, Inc. has a consensus price target of $37.50, signalling upside risk potential of 33.31%. On the other hand PACS Group, Inc. has an analysts' consensus of $44.20 which suggests that it could grow by 7.1%. Given that The Pennant Group, Inc. has higher upside potential than PACS Group, Inc., analysts believe The Pennant Group, Inc. is more attractive than PACS Group, Inc..

The Pennant Group, Inc. has a beta of 1.282, which suggesting that the stock is 28.198% more volatile than S&P 500. In comparison PACS Group, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Pennant Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACS Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Pennant Group, Inc. pays -- of its earnings as a dividend. PACS Group, Inc. pays out -- of its earnings as a dividend.

The Pennant Group, Inc. quarterly revenues are $229M, which are smaller than PACS Group, Inc. quarterly revenues of $1.3B. The Pennant Group, Inc.'s net income of $6.9M is lower than PACS Group, Inc.'s net income of $52.3M. Notably, The Pennant Group, Inc.'s price-to-earnings ratio is 37.18x while PACS Group, Inc.'s PE ratio is 39.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Pennant Group, Inc. is 1.17x versus 1.31x for PACS Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.